27Nov/13

Teva Announces Additional Regulatory Exclusivity for TREANDA … – Business Wire (press release)

Monoclonal Anti-CD20 Antibodies

Drug Discovery & Development

Teva Announces Additional Regulatory Exclusivity for TREANDA …
Business Wire (press release)
TREANDA is indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Important Safety Information.
FDA grants Teva’s Treanda orphan drug statusGlobes
Teva Gets Additional Exclusivity for TreandaDrug Discovery & Development
Cancer drug Treanda gets orphan status, but that won’t save Teva’s shrinking …FiercePharma

all 12 news articles »
27Nov/13

Research and Markets: Monoclonal Antibodies Market for Breast Cancer to More … – 4-traders (press release)

Antibodies

Research and Markets: Monoclonal Antibodies Market for Breast Cancer to More …
4-traders (press release)
The company’s latest report* states that this double-digit increase will be driven mainly by the uptake of two recent approvals, Perjeta and Kadcyla, along with the rapid year-on-year growth in specialty pharmaceuticals in the US, which boasts the …

and more »
27Nov/13

Research and Markets: Monoclonal Antibodies Market for Breast Cancer to More … – Business Wire (press release)

Antibodies

Research and Markets: Monoclonal Antibodies Market for Breast Cancer to More …
Business Wire (press release)
The company’s latest report* states that this double-digit increase will be driven mainly by the uptake of two recent approvals, Perjeta and Kadcyla, along with the rapid year-on-year growth in specialty pharmaceuticals in the US, which boasts the …

and more »
26Nov/13

Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of … – Sacramento Bee

Antibodies

Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of …
Sacramento Bee
Summary GBI Research has released the pharmaceutical report “Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth”. The current market for breast cancer consists of five …

and more »
26Nov/13

Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of … – PR Newswire (press release)

Antibodies

Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of …
PR Newswire (press release)
GBI Research has released the pharmaceutical report “Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth”. The current market for breast cancer consists of five monoclonal …

and more »
26Nov/13

Red Squirrels May be Developing Antibodies Against Squirrelpox (Video) – Science World Report

Antibodies

Red Squirrels May be Developing Antibodies Against Squirrelpox (Video)
Science World Report
Squirrelpox has helped devastate red squirrel populations in the United Kingdom. Now, there may be a bit of good news when it comes to this disease. It turns out that the populations of red squirrels are not only recovering, but they’re also developing …
Red squirrels showing resistance to lethal pox virusIrish Independent

all 6 news articles »
26Nov/13

Bendamustina più Rituximab contro il Linfoma non-Hodgkin – informazione.it (Comunicati Stampa)

Monoclonal Anti-CD20 Antibodies

Bendamustina più Rituximab contro il Linfoma non-Hodgkin
informazione.it (Comunicati Stampa)
Roma, 26/11/2013 (informazione.it – comunicati stampa) I risultati di uno studio, pubblicato su “The Lancet”, dimostrano che l’associazione bendamustina più rituximab in pazienti con linfoma non-Hodgkin, indolente e mantellare, raddoppia la …

and more »